Varian Medical Systems, Inc. (NYSE:VAR)
The Company designs, manufactures, sells and services advanced equipment and software products for treating cancer with radiation.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
ofcourse the company is good, but I think investors over-reacted to bring it down by about 8% in a day. I am sure it will go up eventually in the 3rd quarter. Good time to buy.
Recs
Showed up on my "stock-of-the-day" radar here in caps-land.
Adding on the dip as the stock is getting punished today for lowering 2Q revenue estimates.
Recs
Varian Medical Systems is engaged in manufacturing and selling of integrated cancer therapy systems worldwide. Under its Oncology Systems segment, it designs, manufactures, sells and services hardware and software products for treating cancer with radiation. Its X-ray products segment manufactures and sells X-ray imaging components and subsystems namely X-ray tubes and flat panel detectors. Oncology Systems generate 84% of revenues, whereas X-ray products and others comprised 16% of revenues for year ended September 2006.
Intensity Modulated Radiation Therapy (IMRT) has become a well-accepted standard of treatment for cancer and more clinics every year, from university hospitals to local community clinics, continue to adopt treatments. The radiation oncology market is growing globally, as the annual cancer rates are projected to increase by 50% across the world to 15 million cases by 2020. As per World Cancer Report, the predicted sharp increase will be mainly due to trends in smoking prevalence and the growing adoption of unhealthy life styles. This augurs well for company’s Oncology products particularly in the international markets, which are under-equipped with radiation therapy systems to address the growing cancer incidence.
Very recently the company completed acquisition of ACCEL Instruments GmbH, supplier of scientific research instruments and proton therapy systems for cancer treatment. The company has an opportunity to build a strong business model, based on improving cancer care with a clinically practical and affordable system for proton therapy. The shares of Varian Medical Systems offers good opportunity for long term investors as the rise in cancer cases, coupled with increase in sophistication of new treatment processes, generates demand for company products.
Recs
Radiation cancer therapy plus imaging for homeland security applications
Recs
Innovative cancer treatment.
Recs
Innovative products, and cancer isn't going away anytime soon. Thanks to FreethinkerKW for bringing this one to my attention.
Recs
recovery time
Recs
this stock has split once already, and we are looking for cancer breakthroughs so I think that it will continue to do well
Recs
New cancer fighting equipment soon to be released.
Recs
Good and solid balance sheet. Continuously making money. Continuously developing their products. Good demographic play. Excellent for long term holding.
Recs
The leader is cancer therapy and radiation planning systems which had a good report but not good enough for some folks so I am buying the pullback. First nibble at $46.25 on the drop this morning premarket. Will buy more about every 5%-7.5% or so.
Recs
Port Security
Recs
Look for this stock to make gains. Currently near its low.
Recs
Varian's IMRT cancer treatment is successful and gaining traction. The company has steadily grown and has a habit of beating estimates. Great cash flow and buying back shares.
Recs
They have equipment no one else has. Long history of profit.
Recs
earnings momentum
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 41 - 56 of 56 : « Previous 1 2 3